The Indian market is expected to trade higher on January 15, supported by positive global cues. Nifty futures gained 0.51% on ...

Shares of several companies including BSE, SBI Life Insurance, UltraTech Cement, and Ambuja Cements, among others, will be in ...

The Nifty50 had a gap-up opening at 23,216.50 on Tuesday and ended the day at 23,176.05, up 0.39% from Monday's close.

Biocon’s shares surged over 7% on January 14, 2025, after HSBC upgraded its rating to ’Buy’ with a target price of ₹430, ...

The State Bank of India (SBI) provides various investment schemes to senior citizens and others, including the Amrit Vrishti ...

Indian stock market rebounded on January 14, marking a recovery after four consecutive sessions of selling pressure that had ...

Finance Minister Nirmala Sitharaman is set to present the Union Budget for Fiscal 2025-26 on Saturday, February 1. It is one ...

HSBC's base case target suggests 10 per cent upside over the prevailing stock price. Its bull case target suggests 40 per ...

So, buy-on decline to continue over here, but just for intraday perspective, overall swings will continue and one needs to be ...

The stock has gained 9.66% in the last month, 7.99% over the past six months, and an impressive 37.98% in the last year.

HSBC expects an operational turnaround for Biocon, driven by major biosimilar launches and a rebound in generics sales. The ...

Motilal Oswal (MOSL) has reiterated its "Buy" rating on HCL Technologies, setting a target price of Rs 2,400, which implies a ...